SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims – GlobeNewswire

In addition, the Company was notified by FDA that the FT218 New Drug Application (‘NDA’) patent statement pertaining to US Patent No. 8,731,963 (the ‘ …